CCL2 also accelerates tumor development by increasing angiogenesis in several kinds of cancers, such as hepatocellular carcinoma [68], prostate cancer, esophageal squamous carcinoma, and gastric carcinoma [25] (Figure 2). Here, CCL2 is linked to hepatocellular carcinoma.